| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 33.3× | −1.8× | |
| Price / Book | 1.3× | 2.1× | |
| Price / Sales | 1.6× | 4.0× | |
| Price / Free cash flow | 9.2× | −1.6× | |
| EV / EBITDA | 10.5× | −1.2× | |
| Earnings yield | 3.0% | −14.1% | |
| Free cash flow yield | 10.9% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.00 | −1.81% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.56 | −1.51% | $634.47B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.05 | −0.40% | $501.95B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.34 | −0.39% | $379.99B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.99 | −2.21% | $355.24B | 19.9× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.23 | −0.67% | $279.72B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.60 | −1.14% | $264.58B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.06 | −1.25% | $247.01B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.65 | −1.04% | $239.31B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.51 | −0.43% | $194.07B | 22.9× | 37.5% | +26.7% |
